Neuromodulators for the treatment of headache disorders and fibromyalgia

Curr Pain Headache Rep. 2008 Oct;12(5):333-7. doi: 10.1007/s11916-008-0056-8.

Abstract

Migraine and fibromyalgia are prevalent and disabling disorders with few preventive medications approved by the US Food and Drug Administration (FDA). Neuromodulators (or antiepileptic drugs; AEDs) are often effective in the treatment of these conditions. Divalproex sodium and topiramate are FDA-approved AEDs for migraine. For fibromyalgia, pregabalin has recently been approved in the United States. We review the use of AEDs in the preventive treatment of these highly prevalent disorders.

Publication types

  • Review

MeSH terms

  • Fibromyalgia / drug therapy*
  • Fibromyalgia / epidemiology*
  • Fibromyalgia / physiopathology
  • Headache / drug therapy*
  • Headache / epidemiology*
  • Headache / physiopathology
  • Humans
  • Neurotransmitter Agents / therapeutic use*

Substances

  • Neurotransmitter Agents